View online Forward to a friend   |   Facebook   |   Twitter
Pharmaceutical Outsourcing
Featured Articles   |   Featured Partners   |   Videos   |   Service Listings   |   Industry News   |   Events
February 25, 2016
learn more
Newsletter Sponsor
   Don't miss out on your Digital Edition Subscription
Secure your COMPLIMENTARY subscription now!
Do you enjoy the Digital Edition of Pharmaceutical Outsourcing? If so, sign up now to continue receiving the complimentary subscription through the next year.

more info

» Industry News
 
more news
» Featured Articles
The Global Outlook for Generics, Biosimilar and API Manufacturers: Trends, Opportunities & Challenges
The Global Outlook for Generics, Biosimilar and API Manufacturers: Trends, Opportunities & Challenges
Strong forces continue to shape world pharmaceutical markets, most of which point to continued market share and volume growth for generics. As global R&D spend stays flat, regulations continue to ... read more »
Will Biosimilars Make a Difference for the CMO/CDMO Market?
Will Biosimilars Make a Difference for the CMO/CDMO Market?
Given that over $60 billion of biopharmaceutical sales will lose patent protection by 2020, it is not surprising that most major biologics manufacturers have established biosimilar development ... read more »
more articles
 
» Featured Video
learn more
  The Power to Make: A Virtual Tour of Althea
The Power to Make: A Virtual Tour of Althea
Althea is a contract pharmaceutical development and manufacturing organization that supports the drug development process all the way from early-stage clinical trials through commercial manufacturing.... read more »
learn more
  Webinar: Why Innovative Drug Delivery Solutions are Needed for Today’s Patients
Webinar: Why Innovative Drug Delivery Solutions are Needed for Today’s Patients
Kevin Haehl, General Manager for Unither Pharmaceuticals, North America, discusses the impact that innovative drug delivery solutions have for patients and why it is so important to pursue these ... read more »

more videos
 
» Featured Whitepaper
Risk Assessment, Implementation and Validation of Elemental Impurities for ICH Q3D, USP and EP 5.20
Risk Assessment, Implementation and Validation of Elemental Impurities for ICH Q3D, USP <232><233> and EP 5.20
On December 16, 2014 the ICH Working Group published the elemental impurities guideline into the current ver¬sion step 4. The aim of this control ... read more »
Effective EDC Should Be Accessible and Affordable for All Clinical Trials
Effective EDC Should Be Accessible and Affordable for All Clinical Trials
All research efforts deserve to benefit from advanced IT solutions. Modular, cloud-based electronic data capture platforms enable efficient management... read more »
more articles
 
» Events
 
more events
This information is being brought to you because you are a subscriber to
Pharmaceutical Outsourcing.

To ensure delivery to your inbox,
please add newsletters@pharmoutsourcing.com to your address book.

Manage your Subscription |  Unsubscribe  | Contact Pharmaceutical Outsourcing


Pharmaceutical Outsourcing
164 Townsend St. Unit 2
San Francisco, CA 94107 USA